http://www.in-pharmatechnologist.com/ Breaking News on Pharmaceutical Technology en-gb ℗ & © 2009 Decision News Media fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) Sat, 07 Nov 2009 16:24:11 +0100 eZ Components Feed 1.2.1 (http://ezcomponents.org/docs/tutorials/Feed) http://www.rssboard.org/rss-specification 60 http://www.in-pharmatechnologist.com/var/plain_site/storage/images/rss-feeds/in-pharmatechnologist-podcast/1263917-5-eng-GB/in-PharmaTechnologist-Podcast.gif http://www.in-pharmatechnologist.com/ Fabien Scantamburlo Clean fabien.scantamburlo@decisionnews.com Fabien Scantamburlo in-PharmaTechnologist Podcast Breaking News on Pharmaceutical Technology http://www.in-pharmatechnologist.com/Industry-Drivers/OctoPlus-Glycotope-Merck-KGaA-and-SCM-Pharma-on-BioPh-2009 How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/OctoPlus-Glycotope-Merck-KGaA-and-SCM-Pharma-on-BioPh-2009 Thu, 29 Oct 2009 11:00:00 +0100 gareth.macdonald@decisionnews.com BioPh, P-Mec, Glycotope, CPhI, ICSE, biologics, biomanufacturing, small molecules, CMO, OctoPlus, Merck, SCM Pharma OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009 How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event. http://www.in-pharmatechnologist.com/Materials-Formulation/Cargill-discusses-Zerose-erythritol-s-development Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/Cargill-discusses-Zerose-erythritol-s-development Mon, 19 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com Cargill discusses Zerose erythritol's development Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008. http://www.in-pharmatechnologist.com/Materials-Formulation/CPhI-2009-Road-to-recovery As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/CPhI-2009-Road-to-recovery Thu, 15 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com CPhI CPhI 2009 - Road to recovery? As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. http://www.in-pharmatechnologist.com/Industry-Drivers/Gene-therapy-to-drive-viral-and-biologics-market-says-SAFC SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/Gene-therapy-to-drive-viral-and-biologics-market-says-SAFC Wed, 14 Oct 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com viral, SAFC Pharma, gene therapy, biologics Gene therapy to drive viral and biologics market, says SAFC SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale. http://www.in-pharmatechnologist.com/Industry-Drivers/CPhI-2009-show-preview We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/CPhI-2009-show-preview Thu, 08 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com Madrid, CPhI CPhI 2009 show preview We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT Wed, 01 Jul 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com process FT-NIR, Thermo Fisher Scientific, Siemens, Sipat TFS and Siemens hope to have process analysis down PAT US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. http://www.in-pharmatechnologist.com/Materials-Formulation/Symyx-launches-CDMO At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/Symyx-launches-CDMO Wed, 03 Jun 2009 11:00:00 +0200 nick.taylor@decisionnews.com Symyx Symyx launches CDMO At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. http://www.in-pharmatechnologist.com/Industry-Drivers/Meet-Our-New-Owners Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of in-PharmaTechnologist. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/Meet-Our-New-Owners Wed, 03 Jun 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com Decision News Media, William Reed Business Media Meet Our New Owners Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of in-PharmaTechnologist. http://www.in-pharmatechnologist.com/Industry-Drivers/BIO-2009-snapshot-of-an-evolving-biotech-industry in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/BIO-2009-snapshot-of-an-evolving-biotech-industry Fri, 22 May 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com biosimilars, healthcare, Ernst & Young, biotech, collaboration BIO 2009: snapshot of an evolving biotech industry in-Pharmatechnologist's Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings. http://www.in-pharmatechnologist.com/Industry-Drivers/France-helps-clusters-battle-for-bio-bucks HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe". gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/France-helps-clusters-battle-for-bio-bucks Wed, 20 May 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com France helps clusters battle for bio bucks HEM Pierre Vimont, Ambassador of France to the US, was at BIO 2009 talking about the measures his nation have taken to attract biotechs, including the introduction of the "most favourable R&D tax in Europe".